Hq Speclt Pharma Company Profile
What is the competitive landscape for HQ SPECLT PHARMA
HQ SPECLT PHARMA has six approved drugs.
Drugs and US Patents for Hq Speclt Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hq Speclt Pharma | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 062772-007 | Apr 15, 1993 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hq Speclt Pharma | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 062772-008 | Apr 15, 1993 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Hq Speclt Pharma | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 062772-006 | Apr 15, 1993 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hq Speclt Pharma | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 062772-005 | Apr 15, 1993 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Hq Speclt Pharma | AMPICILLIN AND SULBACTAM | ampicillin sodium; sulbactam sodium | INJECTABLE;INJECTION | 065176-001 | Nov 30, 2005 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hq Speclt Pharma | PENICILLIN G POTASSIUM | penicillin g potassium | INJECTABLE;INJECTION | 065149-002 | Jul 23, 2009 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

